Japan’s Taisho Pharma Aims For Southeast Asia OTC Market Expansion
This article was originally published in PharmAsia News
Executive Summary
Taisho Pharmaceutical’s goal of building a portfolio of drugs for lifestyle diseases will first target an anti-obesity drug it is readying for the market.